| Autor: |
Scarà A; San Carlo di Nancy Hospital-GVM, 00165 Roma, Italy.; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy., Palamà Z; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.; Electrophysiology Unit 'Casa di Cura Villa Verde', 74121 Taranto, Italy., Robles AG; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.; Electrophysiology Unit 'Casa di Cura Villa Verde', 74121 Taranto, Italy.; Department of Cardiology, 'L. Bonomo' Hospital, 76123 Andria, Italy., Dei LL; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy., Borrelli A; San Carlo di Nancy Hospital-GVM, 00165 Roma, Italy.; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy., Zanin F; San Carlo di Nancy Hospital-GVM, 00165 Roma, Italy., Pignalosa L; San Carlo di Nancy Hospital-GVM, 00165 Roma, Italy., Romano S; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy., Sciarra L; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy. |
| Abstrakt: |
Heart failure (HF) represents a significant global health challenge that is still responsible for increasing morbidity and mortality despite advancements in pharmacological treatments. This review investigates the effectiveness of non-pharmacological interventions in the management of HF, examining lifestyle measures, physical activity, and the role of some electrical therapies such as catheter ablation, cardiac resynchronization therapy (CRT), and cardiac contractility modulation (CCM). Structured exercise training is a cornerstone in this field, demonstrating terrific improvements in functional status, quality of life, and mortality risk reduction, particularly in patients with HF with reduced ejection fraction (HFrEF). Catheter ablation for atrial fibrillation, premature ventricular beats, and ventricular tachycardia aids in improving left ventricular function by reducing arrhythmic burden. CRT remains a key intervention for selected HF patients, helping achieve left ventricular reverse remodeling and improving symptoms. Additionally, the emerging therapy of CCM provides a novel opportunity for patients who do not meet CRT criteria or are non-responders. Integrating non-pharmacological interventions such as digital health alongside specific medications is key for optimizing outcomes in HF management. It is imperative to tailor approaches to individual patients in this diverse patient population to maximize benefits. Further research is warranted to improve treatment strategies and enhance patient outcomes in HF management. |
